Patent details

EP1092431 Title: Lasofoxifene compositions

Basic Information

Publication number:
EP1092431
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP003081528
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Lasofoxifene compositions
French Title of Invention:
Compositions contenant du lasofoxifène
German Title of Invention:
Lasofoxifen enthaltende Zusammensetzungen
SPC Number:

Dates

Filing date:
19/09/2000
Grant date:
13/09/2006
EP Publication Date:
13/09/2006
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/04/2001
EP B1 Publication Date:
13/09/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/09/2009
Expiration date:
19/09/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/09/2000
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
13/09/2006
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Thompson David Duane, Pfizer Central Research
Address:
United States (US)

Priority

Priority Number:
156652 P
Priority Date:
29/09/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/40;
Filing date Document type Number of pages